Weight Loss Biotech Gelesis Inches Closer To $52M IPO
Weight-loss capsule developer Gelesis Inc. set terms Thursday for an initial public offering that could raise $52 million, proceeds the biotech said it would use partly to advance its lead product...To view the full article, register now.
Already a subscriber? Click here to view full article